HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
A Phase II, Open Label, Multi-Center, Proof-Of-Concept Study determing whether treatment with
HDV-Interferon (HDV-IFN), by oral or subcutaneous (injection) routes, and ribavirin results
in similar efficacy [Rapid Virologic Response (RVR)] and safety as the reported efficacy and
safety with pegylated alpha-interferon-2a and ribavirin (historical control) in patients with
chronic hepatitis C (treatment naïve by oral route and non-responders by SC route
respectively).